SAN DIEGO–(BUSINESS WIRE)–TriLink BioTechnologies, LLC (TriLink®), a Maravai LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, has been granted a new patent from the China National Intellectual Property Administration (CNIPA), Patent number ZL 2025 1 1246578.X, covering methods of synthesizing RNA molecules. The new patent covers TriLink’s full suite of CleanCap® capping analogs, including its latest M6 analog. CleanCap technology is a critical com
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
